Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-42.24	88.23	-152.75
Graham Fair Price	-34.51	24.19	36.94
PEG	426.35	-0.38	0.07
Price/Book	4.82	7.44	7.09
Price/Cash Flow	inf	0.00	38.31
Prices/Earnings	174.47	52.95	-19.29
Price/Sales	-1.73	6.64	6.75
Price/FCF	inf	0.00	38.31
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	14.84	0.51	0.45
Operating Margin	-19.08	0.06	-0.08
ROA	-60.20	< 0.005	-0.02
ROE	-0.09	0.04	-61.81
ROIC	-0.05	0.03	-41.04
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.02	-0.03	-49.77
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-1.75	1.92	9.79
EPS QOQ	-2.70	1.41	-47.86
FCF QOQ	-0.15	-1.00	-584.83
Revenue QOQ	-0.20	0.13	-32.09
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	154.06	149.67	-2.85
Days Sales Outstanding (DSO)	52.10	45.48	-12.71
Inventory Turnover	0.58	0.60	2.93
Debt/Capitalization	0.43	0.43	-1.52
Quick Ratio	0.53	0.48	-10.04
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	25.69	27.22	5.97
Cash	8.30	6.09	-26.64
Capex	-1.18	0.00	inf
Free Cash Flow	4.76	0.00	inf
Revenue	26.98	30.50	13.03
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.22	1.26	3.38
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-17.23	9.88	-42.69
Naive Interpretation	Member

06 - Financial Health · Weak

Rating